Skip to message. Skip to access key tips.
|
||||
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
||
|
||||
|
||||
|
|
|
Keyboard shortcuts Pressing these keys is the same as clicking their link equivalents. Note: Netscape users don't have to press enter after the shortcut. Mac users - use the CTRL key.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
| » Lycos Worldwide |  |
|
| About Terra Lycos | Help | Jobs | Advertise | Business Development | |
||
|
Skip to message. Skip to access key tips.
|
||||
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
||
|
||||
|
||||
|
|
|
Keyboard shortcuts Pressing these keys is the same as clicking their link equivalents. Note: Netscape users don't have to press enter after the shortcut. Mac users - use the CTRL key.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
| » Lycos Worldwide | |
|
| About Terra Lycos | Help | Jobs | Advertise | Business Development | |
||
|
| Sharing
my impressions of the interview. Dr. James D'Olimpio expressed himself in a casual but articulate manner. He is triple board certified and is associated with the Palliative care at North Shore University Hospital. He only spent about five minutes discussing the drug and the company. He was involved in the development of the studies in Israel and is helping to develop more studies for our FDA. He specifically said he would be careful not to tout an unproven drug such as AVR118 but was very interested in helping the drug be properly tested. The results he has seen have impressed him. He seems very interested in the future of this drug. This looks like a great man to have helping ADVR. Good luck to all!!! (Voluntary Disclosure: Position- Long) |
| Billy,
it was a great interview! Kudos to Dr. James D'Olimpio! It was so nice to hear the voice behind the name. Yes, the discussion was on pallative care and relieving the suffering of the patient. He discussed Dr. Kvorkian and assisted suicide which he doesn't agree with. He said it's the intent of a physician to relieve the suffering of a patient and not by killing the patient intentionally as Dr. Kvorkian did. To identify and refine it correctly you can't relieve suffering by active euthanasia. After the intermission ADVR and AVR118 was discussed. I was very impressed with his presentation on body wasting, trying to reverse weight loss and improve the quality of life. He said this is a very powerful technology platform and is very impressed with the information coming out of the AVR118 clinical trials in Israel which we'll modify and model it to get through the FDA. He said that the AVR118 platform makes the patient feel better without making them feel sick first and to date has shown no indication of human toxicity and is an immunomodulator, etc., etc., etc. All in all, a very impressive interview. Foxy |
| If
Dr. Olimpio is an example of the quality people working with ADVR, we have reason to be optimistic. He appeared to be extremely well educated, very experienced and highly articulate. His background appears custom made for the work he is doing with ADVR 118, which he discussed at length during the interview. He was in no way hyping the drug, but clearly stated that he was very interested in ADVR 118 because of its unique and promising characteristics. He talked about the trials in Isreal and how those trials would be remodeled to allow the clinical trials in the US to go forward. He talked about the great value to cancer and aids patients to provide treatment to prevent the wasting effect that occurs while these patients are being treated for other aspects of the disease. There were many interesting and important topics covered in this half hour interview which was broadcast from Nassau Community College FM radio. This college is located in Nassau County, New York and you might want to contact them for a transcript of the interview. If I can get one, I'll post it. This interview was a real treat for the holidays. Merry Christmas and Happy Chanukah! and a Prosperous New Year! (Voluntary Disclosure: Position- Long; ST Rating- Buy; LT Rating- Buy) |
